Clinical trial
Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study
NCT04979247 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 15, 2021
- Completion date
- January 10, 2024
- Enrollment
- 204 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
major surgery